Allterum Therapeutics, Inc

1 clinical trials · Sponsor

Record	Firm	Date
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect. (NCT07586618)	Allterum Therapeutics, Inc	2026-06-01

Every clearance here is in the API, with alerts when new ones post.